DXA assessment and fracture prevention in hormone positive breast cancer patients after treatment initiation with aromatase inhibitors: A registry-based cohort study

BACKGROUND: Several guidelines have been proposed to prevent aromatase inhibitors induced bone loss (AIBL), but there is scarce data on their endorsement in clinical practice. AIM: To assess bone health evaluation and fracture prevention in postmenopausal women with estrogen receptor (ER)-positive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouach, Vanessa, Greenman, Yona, Chodick, Gabriel, Goldshtein, Inbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474058/
https://www.ncbi.nlm.nih.gov/pubmed/37664159
http://dx.doi.org/10.1016/j.jbo.2023.100501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474058/
https://www.ncbi.nlm.nih.gov/pubmed/37664159
http://dx.doi.org/10.1016/j.jbo.2023.100501

Ejemplares similares